Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors

Title
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
Authors
Keywords
-
Journal
INVESTIGATIONAL NEW DRUGS
Volume 27, Issue 5, Pages 453-460
Publisher
Springer Nature
Online
2008-11-15
DOI
10.1007/s10637-008-9200-x

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started